<DOC>
	<DOCNO>NCT00477477</DOCNO>
	<brief_summary>This study design evaluate efficacy two diet , low glycemic load diet low saturate fat diet , treatment adolescent heart disease risk factor associate overweight , high blood pressure , pre-diabetes , cholesterol problem . The objective study determine diet improves risk factor . The design study modify feed study , request participant eat food provide study 8 week , day per week . Dietary counsel phone continue 2 6 month study effect maintenance period assess 6 month time .</brief_summary>
	<brief_title>Nutritional Treatment Overweight Adolescents With Cardiovascular Risk Factors ( PowerUp )</brief_title>
	<detailed_description>The prevalence obesity overweight among child high , increase . Metabolic syndrome , recently recognize consequence obesity , know confer elevate risk cardiovascular ( CV ) disease diabetes type 2 adult . The primary treatment metabolic syndrome lifestyle modification , include dietary change . However , little known dietary composition , distinct decrease caloric intake weight loss , alters metabolic syndrome abnormality child . Moreover , optimal pediatric nutritional strategy prevention treatment metabolic syndrome unknown . The overall goal research protocol evaluate two nutritional approach pediatric metabolic syndrome post-pubertal overweight adolescent , low saturate fat diet low glycemic load ( GL ) diet . The design protocol short-term , modify feed study evaluate efficacy two nutritional approach equal weight loss goal . Outcome measure include percent change baseline end intervention period ( 8 week ) metabolic abnormality , inflammatory cytokine adipokines , non-invasive test vascular function . Metabolomic profile measure baseline 8 week subset participant . To facilitate compliance adherence , participant choose menu food choice food deliver participant home supply meal snack participant consume . Participants receive weekly personal nutritional counseling enhance compliance frequent phone follow-up . Subsequent feed portion intervention , participant counsel phone least monthly basis effect maintenance phase measure 6 month .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Pediatric Obesity</mesh_term>
	<criteria>Ages 8 17 year old Overweight , define BMI â‰¥ 85th % tile age gender At least two CV risk factor typical metabolic syndrome include insulin resistance , high borderline blood pressure , low HDL , high TG Insulin &gt; 10 u/L Able attend study visit week participant 's home , eat meal provide Children 's Hospital CTSA Boston MA supply meal snack Nonsmoker Able understand/speak English Informed consent participate parent legal guardian . Adolescents must also provide write assent participate study . Preexisting physician diagnosis major medical illness history major medical illness include limited heart , kidney liver disease , cancer , endocrinopathy include thyroid disorder , genetic syndrome psychiatric illness , also include vasculitides Kawasaki disease rheumatologic disorder ; diabetes type I II , evidence severe fatty liver , hypertension require pharmacologic treatment , history current diagnosis major eat disorder Current anticipate pregnancy Weight 275 lb ( 125 kg ) Abnormalities initial screen assessment require pharmacotherapy urgent treatment , familial hyperlipidemia , end organ effect hypertension , metabolic abnormality diabetes Taking prescription medication nonprescription substance affect cholesterol level , blood pressure , insulin sensitivity ( include limit oral glucocorticoid , oral contraceptive , neuropsychiatric agent , antiepileptic , HMGCoA reductase inhibitor , bile acid bind cholesterol transport inhibitor among others ) use alcohol illicit substance . Anticipated difficulty participatory requirement study include food allergy , significantly restrict food preference , difficulty assess research staff .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>overweight</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>adolescent</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>risk factor</keyword>
	<keyword>hypertension</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>inflammation</keyword>
	<keyword>coagulopathy</keyword>
</DOC>